Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study

Introduction

The average life expectancy in the world has increased substantially in the past few decades.1 The aging of the population has led to a high prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer. Although people live longer, older individuals often live with disabilities and chronic diseases.2 People with chronic diseases including cancer, cardiovascular disease, and diabetes have a shorter life expectancy than do their peers without these chronic conditions.345 Estimates of the loss in life years due to these chronic conditions range from 7.5 to 20 years, depending on the methods used and the characteristics of the study population.345

Modifiable lifestyle factors including smoking, physical activity, alcohol intake, body weight, and diet quality affect both total life expectancy and incidence of chronic diseases.6789 Studies have shown that smoking, inactivity, poor diet quality, and heavy alcohol consumption contribute up to 60% of premature deaths and 7.4-17.9 years’ loss in life expectancy.7 10 11 12 13 14 15 Nevertheless, little research has looked at how a combination of multiple lifestyle factors may relate to life expectancy free from the major diseases of diabetes, cardiovascular disease, and cancer.15 16 17 18 19

Because estimates of life expectancy free of chronic diseases take into account both morbidity and mortality, these estimates can be useful metrics for health professionals and the general public, as well as enabling policy makers to better estimate future healthcare costs and to plan for healthcare needs.20 21 22 In a previous analysis, we estimated the effect of healthy lifestyles on the overall life expectancy.23 In this study, we examine the effect of healthy lifestyle factors on life expectancy free of cancer, cardiovascular disease, and type 2 diabetes, using data from up to 34 years of follow-up in the Nurses’ Health Study (NHS) and 28 years of follow-up in the Health Professions Follow-up Study (HPFS).

 

Methods

Study population

This study was embedded in the NHS and the HPFS. The NHS began in 1976, when 121 700 female nurses aged 30-55 years were included and provided information on medical, lifestyle, and other health related variables.24 In 1980, 92 468 nurses also completed a validated food frequency questionnaire. The HPFS was established in 1986, when 51 529 male US health professionals (dentists, optometrists, osteopaths, podiatrists, pharmacists, and veterinarians) aged 40-75 years completed a mailed questionnaire about their medical history and lifestyle.25 In both cohorts, self administered questionnaires have been sent every two years to update the information and identify newly diagnosed cases of various diseases. For this analysis, we used 1980 as the baseline for the NHS and 1986 for the HPFS. We excluded participants already diagnosed as having any of the three outcomes (cancer, cardiovascular disease, and diabetes, n=15 118), those with implausible energy intakes (women: <500 or >3500 kcal/day; men: <800 or >4200 kcal/day), and those with missing values for body mass index, physical activity, alcohol, or smoking at baseline (n=17 317), leaving 111 562 participants (73 196 women and 38 366 men) for analysis. Participants who had missing lifestyle factors at baseline had similar baseline characteristics to those without missing information (supplementary table A).

The NHS and HPFS cohorts were followed across the follow-up periods using similar questionnaires on diet, exercise, smoking status, and other factors (questions on the use of postmenopausal hormone replacement therapies and reproduction related questions were asked in the NHS only). Information on age, ethnicity, use of multivitamins, regular use of aspirin, postmenopausal hormone use (NHS only), and the presence or absence of a family history of diabetes, cancer, or myocardial infarction (in first degree relatives) was collected via biennial questionnaires.

 

Assessment of lifestyle behaviors

We derived a healthy lifestyle score based on information on five lifestyle factors—diet, smoking, physical activity, alcohol consumption, and body mass index (BMI). Diet was assessed in the NHS and HPFS by using a validated food frequency questionnaire assessing how often, on average, a participant had consumed a specified amount of a list of foods during the previous year.24 Quality of diet was assessed using the Alternate Healthy Eating Index (AHEI) score, which is significantly associated with risk of cardiovascular disease and other chronic diseases in the general population.26 We defined a healthy diet as an AHEI score in the top 40% of each cohort distribution.7 Physical activity levels were assessed using a validated questionnaire and updated every two to four years.27 We estimated the number of hours per week spent in moderate to vigorous activities (including brisk walking) requiring the expenditure of at least 3 metabolic equivalents of task (METs) per hour. We classified low risk as at least 30 minutes of moderate or vigorous activity daily (3.5 h/week). Height and weight were self reported and used to calculate BMI as weight (kg) divided by height (m2). We defined a healthy body weight as a BMI in the range of 18.5-24.9.

Self reported smoking status and the number of cigarettes smoked were updated biennially. We defined never smokers as participants who reported never smoking, current smokers as participants who reported active smoking on the questionnaire, and ever smokers as participants who had smoked in the past but did not report active smoking on the time varying questionnaire. On each questionnaire, current smokers were further classified as smoking one to 14, 15 to 24, or 25 or more cigarettes per day. The food frequency questionnaire also collected alcoholic beverage consumption, including red and white wine separately (4 ounces, increasing to 5 ounces in 2006), beer (one glass, can, or bottle), and liquor (one drink or shot). We multiplied the amount of alcohol in grams per specified portion size by servings per day, determined the midpoint of the frequency category, and summed across all beverages to estimate the average alcohol consumption (g/day). We defined moderate alcohol consumption as 5-15 g/day for women and 5-30 g/day for men, consistent with the guidelines for moderate alcohol intake in the US.28

Our previous studies using objective measurements had documented the validity of these lifestyle data. A previous validation study showed a correlation of 0.97 between self reported weight and weight measured by a technician.25 The correlations between physical activity reported in diaries and that in the questionnaire was 0.62 in women and 0.58 in men.2729 In addition, independent associations have been observed between physical activity and several biomarkers of obesity and cardiovascular disease risk such as high density lipoprotein cholesterol, leptin, and C peptide.30 Validation studies of the food frequency questionnaire with dietary records indicated an average correlation of 0.63 for all nutrients after adjustment for energy intake and variation in the seven day dietary records.24 In addition, correlations with nutrient biomarkers in our study population provided objective evidence for the validity of the food frequency questionnaire.3132 Correlation coefficients between the food frequency questionnaire and four single week diet records for ethanol were 0.90 in the NHS and 0.86 in the HPFS.33 Ethanol intake assessed through the food frequency questionnaire was also significantly correlated with serum high density lipoprotein cholesterol (r=0.33 for NHS; r=0.38 for HPFS). Another validation study among 2485 women participating in the NHS reported that smoking level was strongly associated with toenail nicotine concentration (r=0.63).34

For each low risk lifestyle factor, the participant received a score of 1 if he or she met the criterion for low risk, and 0 otherwise. The sum of these five scores together gave a final low risk lifestyle score ranging from 0 to 5, with higher scores indicating a healthier lifestyle. As the number of cases among the group with the highest lifestyle score was small, especially mortality among participants with prevalent diseases, we combined participants with four or five low risk factors into one group.

Because lifestyle factors may affect mortality risk over an extended period of time, to best represent long term lifestyle we applied time varying lifestyle information during follow-up, in which mortality risks were predicted by the repeated measurements of these variables during the follow-up periods. The average response rate for the lifestyle risk factors during follow-up was approximately 94% for the NHS and 90% for the HPFS. We calculated average levels of lifestyle factors by using the latest two repeated measurements for our primary analysis of diet, physical activity, and alcohol consumption.35 For non-respondents to both questionnaires, we used the last available value carried forward. For AHEI score and alcohol consumption, we calculated the average on the basis of four year repeated measurements. Smoking status was estimated on the basis of both smoking history and most recent status updated every two years and classified into five categories: never smoking, past smoking, and current smoking of 1-14, 15-24, and 25 or more cigarettes per day. To minimize reverse causality, we applied the lifelong maximum BMI by age at risk.36 For example, we applied the maximum value of BMI at age 18 and BMI in 1980 to predict mortality between 1980 and 1982 and the maximum value of BMI at age 18, BMI in 1980, and BMI in 1982 to predict mortality between 1982 and 1984, and so forth.

 

Ascertainment of deaths and non-fatal chronic diseases

In the NHS and HPFS, most of the deaths were identified through family members or the postal system in response to the follow-up questionnaires. We searched the National Death Index to identify deaths among all study participants, with a high sensitivity (97.7%) and specificity (100%).37

Self reported diagnoses of cancer, myocardial infarction, and stroke were collected on biennial questionnaires, and participants who reported a new diagnosis were asked for permission to acquire their medical records and pathologic reports. Study physicians, blinded to exposure information, reviewed medical records to confirm the diagnosis. We included all cancers as outcomes except non-melanoma skin cancer. Non-fatal cardiovascular disease outcomes comprised non-fatal myocardial infarction and non-fatal stroke. We classified non-fatal myocardial infarctions as confirmed if the criteria of the World Health Organization were met specifically on the basis of symptoms and either electrocardiographic changes or elevated cardiac enzyme concentrations. We classified stroke cases according to the criteria of the National Survey of Stroke, which required evidence of a neurologic deficit with a sudden or rapid onset that persisted for more than 24 hours. Pathologically confirmed cerebrovascular conditions that were caused by an infection, trauma, or malignancy were not counted as outcomes. Cancer, coronary heart disease, and stroke events for which confirmatory information was obtained by interview or letter but without access to medical records were also included as outcomes. The overall proportion of cases confirmed by medical records in the NHS and HPFS were 82.9% for cancer, 74.4% for coronary heart disease, and 64.5% for stroke.

Cases of type 2 diabetes were identified by self report and confirmed by a validated supplementary questionnaire.38 39 For cases before 1998, we applied the National Diabetes Data Group criteria. We used the American Diabetes Association diagnostic criteria for confirmation from 1998 onward. The validation of self reported type 2 diabetes diagnosis in the NHS has been documented previously.38 39

 

Statistical analysis

We used population based multistate life tables to calculate the differences in life expectancy and years lived with and without major chronic diseases for each lifestyle factor and the total lifestyle factor score. To assess the association between the number of low risk factors and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes, we took into account three states (disease free, presence of disease, and death), and three transitions between states (from non-disease to incident disease, from non-disease to mortality among participants free of major chronic disease, and from disease diagnosis to mortality among those with disease). Subsequently, we built multistate life tables allowing for the occurrence of the transitions. As shown in supplementary figure A, all participants started from state 0 at baseline; both the period between state 0 and state 1 (before disease diagnosis) and the period between state 0 and state 2 (without disease) contributed to the estimated life expectancy free of cancer, cardiovascular disease, or type 2 diabetes; whereas only the patients with cancer, cardiovascular disease, or type 2 diabetes after diagnosis (from state 1 to state 2) contributed to the estimated life expectancy in the presence of the major chronic disease.

We built a total of four multistate life tables—one for a combination of cancer, cardiovascular disease, and type 2 diabetes and three for individual diseases. For each multistate life table, we first derived overall transition rates by a single year of age in the NHS and HPFS, separately, irrespective of the lifestyle factors, for three transitions4: mortality among participants free of the diseases, incident diseases, and mortality among those with the diseases. We considered only the first entry into a state and no subsequent disease event, and no reversal of state was allowed. Secondly, we calculated hazard ratios to assess the relation between the number of low risk factors and the three transitions by using Cox proportional hazards analyses. We used separate time varying Cox proportional hazards models to assess the risk of mortality without disease, risk of incident disease, and risk of mortality among participants with cancer, cardiovascular disease, and type 2 diabetes. Thirdly, we calculated proportions of low risk factors among the sub-study population for each transition. Lastly, we used the hazard ratios combined with the overall transition rates and low risk factor proportions in the multistate life table to calculate total life expectancy and life expectancy with and without diseases for each group of low risk factors. The multistate life tables started at age 50 years and closed at age 105 years. Models were adjusted for age, ethnicity, current multivitamin use, current aspirin use, status with regard to a family history of diabetes, myocardial infarction, or cancer, and, for women, menopausal status and hormone use.

Considering potential bias resulting from changes in diet after the diagnosis of certain diseases, we did a sensitivity analysis in which we stopped updating lifestyle factors at the beginning of the interval in which the participant was diagnosed as having cancer, cardiovascular disease, or diabetes. In another sensitivity analysis, we further classified the past smokers according to the years since smoking cessation.

We used SAS version 9.3 to analyze the data. Statistical significance was set at a two tailed P value of less than 0.05. We used Monte Carlo simulation (parametric bootstrapping) with 10 000 runs to calculate the confidence intervals of the life expectancy estimation with @RISK 7.5.

 

Patient and public involvement

No patients were involved in setting the research question or the outcome measures, nor were they involved in the design and implementation of the study. We plan to disseminate these findings to participants in our annual newsletter and to the general public in a press release.

 

Results

Participants with a higher number of low risk lifestyle factors were more likely to use multivitamin supplements and aspirin (table 1). During 2 270 411 person years of follow-up of women and 930 201 person years of follow-up of men, 34 383 deaths were recorded (21 344 women and 13 039 men).

Table 1

Participants’ characteristics in middle of follow-up period according number of low risk lifestyle factors in Nurses’ Health Study (women) and Health Professionals Follow-up Study (men). Values are numbers (percentages) unless stated otherwise*

 
  No of low risk lifestyle factors
Zero One Two Three Four or five
Nurses’ Health Study (1998) (n=11 749) (n=25 048) (n=19 837) (n=9079) (n=2984
Mean (SD) age, years 63.3 (7.1) 63.6 (7.2) 63.7 (7.2) 63.8 (7.1) 63.6 (6.9)
Mean (SD) body mass index 31.0 (5.3) 29.2 (5.5) 26.6 (5.0) 24.4 (3.5) 23.1 (2.1)
Mean (SD) Alternate Healthy Eating Index score 43.0 (6.8) 46.6 (9.2) 51.4 (9.8) 55.3 (9.3) 58.3 (8.1)
Mean (SD) physical activity, h/week 0.5 (1.0) 0.9 (1.8) 1.9 (3.0) 3.5 (3.8) 5.5 (4.3)
Mean (SD) alcohol consumption, g/day 5.0 (10.8) 4.5 (9.1) 5.1 (8.1) 6.1 (7.4) 7.3 (5.5)
Past smoking 9086 (77.5) 11 314 (45.2) 6822 (34.4) 2658 (29.3) 558 (18.6)
Current smoking 2663 (22.5) 3249 (13.0) 1654 (8.4) 409 (4.5) 50 (1.7)
White 11 524(98.1) 24 496 (97.8) 19 289 (97.2) 8839 (97.4) 2921 (97.9)
Multivitamin use 5412 (46.1) 12 437 (49.6) 10 480 (52.8) 5220 (57.5) 1765 (59.1)
Regular aspirin use 5212 (44.5) 11 457 (45.7) 9145 (46.1) 4358 (47.9) 1535 (51.6)
Family history of diabetes 3583 (30.5) 7394 (29.5) 5296 (26.7) 2170 (23.9) 690 (23.1)
Family history of cancer 1549 (13.3) 3438 (13.7) 2721 (13.7) 1236 (13.6) 419 (14.1)
Family history of myocardial infarction 3153 (26.8) 6273 (25.1) 4787 (24.1) 2069 (22.8) 705 (23.6)
Health Professionals’ Follow-up Study (1998) (n=4052) (n=10 043) (n=10 706) (n=7252) (n=3710)
Mean (SD) age, years 64.3 (9.1) 64.0 (9.2) 63.7 (9.1) 63.7 (9.1) 63.5 (8.9)
Mean (SD) body mass index 29.2 (3.8) 28.2 (3.7) 26.9 (3.5) 25.7 (3.1) 24.2 (2.2)
Mean (SD) Alternate Healthy Eating Index score 42.5 (7.1) 45.6 (9.0) 50.1 (10.1) 54.4 (10.0) 58.9 (8.9)
Mean (SD) physical activity, h/week 0.8 (1.2) 1.9 (3.8) 3.7 (5.6) 5.9 (6.6) 8.0 (7.2)
Mean (SD) alcohol consumption, g/day 13.1 (21.2) 10.6 (15.4) 10.4 (12.4) 10.8 (10.5) 11.3 (8.2)
Past smoking 3465 (85.4) 6256 (62.2) 5258 (49.2) 2711 (37.4) 624 (16.9)
Current smoking 587 (14.6) 848 (8.5) 491 (4.6) 172 (2.4) 21 (0.6)
White 3814 (94.1) 9441 (94.0) 10 117 (94.5) 6818 (94.0) 3526 (95.0)
Multivitamin use 1520 (37.3) 4247 (42.3) 5092 (47.6) 3804 (52.5) 2135 (57.6)
Regular aspirin use 2020 (49.7) 5349 (53.3) 6014 (56.2) 4250 (58.6) 2264 (61.0)
Family history of diabetes 861 (21.2) 2090 (20.8) 2159 (20.2) 1510 (20.8) 709 (19.2)
Family history of cancer 1291 (31.7) 3445 (34.3) 3824 (35.7) 2641 (36.4) 1422 (38.5)
Family history of myocardial infarction 1300 (32.0) 3143 (31.3) 3412 (31.9) 2336 (32.2) 1248 (33.8)
  • * Values other than age are standardized to age distribution of study population.

  • Included cigarette smoking (never smoking), physical activity (≥3.5 h/week moderate to vigorous intensity activity), high diet quality (upper 40% of Alternate Healthy Eating Index), moderate alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body mass index 18.5-24.9)

 

Life expectancies free of cancer, cardiovascular disease, and diabetes in combination

Total life expectancy at age 50 increased with increasing number of low risk lifestyle factors: from 31.7 years to 41.1 years in women and from 31.3 years to 39.4 years in men (fig 1). Regardless of the number of low risk lifestyle factors, the vast majority of life expectancy after 50 was free of cancer, cardiovascular disease, or diabetes (fig 1). At age 50, life expectancy free of cancer, cardiovascular disease, and diabetes was 23.7 (95% confidence interval 22.6 to 24.7), 26.4 (25.2 to 27.4), 29.1 (28.0 to 30.0), 31.8 (30.8 to 32.8), and 34.4 (33.1 to 35.5) years among women who adopted zero, one, two, three, and four or five low risk lifestyle factors, respectively. Life expectancy free of cancer, cardiovascular disease, and diabetes at age 50 was 23.5 (22.3 to 24.7), 24.8 (23.5 to 26.0), 26.7 (25.3 to 27.9), 28.4 (26.9 to 29.7), and 31.1 (29.5 to 32.5) years among men who adopted zero, one, two, three, and four or five low risk lifestyle factors, respectively (table 2). The percentage of life expectancy free of cancer, cardiovascular disease, and diabetes from total life expectancies was 74.8%, 77.6%, 80.1%, 82.2%, and 83.6% among women (75.3%, 75.8%, 76.8%, 77.9%, and 79.0% among men) who adopted zero, one, two, three, and four or five low risk lifestyle factors, respectively.

Fig 1

Fig 1

Estimated life expectancy at age 50 years with and without cancer, cardiovascular disease (CVD), and/or type 2 diabetes among participants of Nurses’ Health Study (women) and Health Professionals Follow-up Study (men) according to number of low risk lifestyle factors. Low risk lifestyle factors included cigarette smoking (never smoking), physical activity (≥3.5 hours/week moderate to vigorous intensity activity), high diet quality (upper 40% of Alternate Healthy Eating Index), moderate alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body mass index <25). Estimates of multivariate adjusted hazard ratios (sex specific) for morbidity and mortality associated with low risk lifestyles compared with people with zero low risk lifestyle factors adjusted for age, ethnicity, current multivitamin use, current aspirin use, family history of diabetes, myocardial infarction, or cancer, and menopausal status and hormone use (women only)

Table 2

Life expectancy (in years) at age 50 years in absence of chronic diseases according to number of low risk lifestyle factors in Nurses’ Health Study (women) and Health Professionals Follow-up Study (men) separately

 
  No of low risk lifestyle factors*
Zero One Two Three Four or five
Women
Free of cancer, CVD, or type 2 diabetes:          
 Life expectancy 23.7 (22.6 to 24.7) 26.4 (25.2 to 27.4) 29.1 (28.0 to 30.0) 31.8 (30.8 to 32.8) 34.4 (33.1 to 35.5)
 Difference Reference 2.6 (2.3 to 2.9) 5.3 (5.0 to 5.6) 8.1 (7.7 to 8.5) 10.6 (10.0 to 11.3)
Free of cancer:          
 Life expectancy 27.6 (26.3 to 28.7) 29.7 (28.5 to 30.9) 31.8 (30.6 to 32.8) 33.8 (32.7 to 34.8) 35.9 (34.6 to 37.1)
 Difference Reference 2.2 (1.9 to 2.4) 4.2 (4.0 to 4.5) 6.2 (5.9 to 6.6) 8.3 (7.8 to 8.9)
Free of CVD:          
 Life expectancy 30.2 (29.9 to 30.6) 32.6 (32.2 to 33.0) 35.0 (34.5 to 35.4) 37.6 (37.0 to 38.1) 40.2 (39.5 to 40.9)
 Difference Reference 2.4 (2.1 to 2.7) 4.7 (4.4 to 5.1) 7.3 (6.9 to 7.7) 10.0 (9.3 to 10.6)
Free of type 2 diabetes:          
 Life expectancy 28.2 (27.0 to 29.3) 31.1 (30.1 to 32.0) 34.3 (33.6 to 35.0) 37.6 (37.0 to 38.3) 40.5 (39.7 to 41.3)
 Difference Reference 2.9 (2.6 to 3.2) 6.1 (5.6 to 6.6) 9.4 (8.7 to 10.2) 12.3 (11.4 to 13.4)
Men
Free of any of cancer, CVD, or type 2 diabetes          
 Life expectancy 23.5 (22.3 to 24.7) 24.8 (23.5 to 26.0) 26.7 (25.3 to 27.9) 28.4 (26.9 to 29.7) 31.1 (29.5 to 32.5)
 Difference Reference 1.2 (0.8 to 1.6) 3.2 (2.7 to 3.6) 4.8 (4.3 to 5.4) 7.6 (6.8 to 8.4)
Free of cancer:          
 Life expectancy 27.3 (25.8 to 28.5) 28.3 (26.8 to 29.6) 29.7 (28.2 to 31.1) 31.0 (29.4 to 32.4) 33.3 (31.6 to 34.8)
 Difference Reference 1.0 (0.7 to 1.3) 2.5 (2.1 to 2.8) 3.7 (3.3 to 4.2) 6.0 (5.4 to 6.7)
Free of CVD:          
 Life expectancy 29.0 (28.5 to 29.6) 30.6 (29.9 to 31.1) 32.8 (32.1 to 33.4) 34.5 (33.8 to 35.2) 37.7 (36.8 to 38.6)
 Difference Reference 1.5 (1.1 to 1.9) 3.7 (3.3 to 4.2) 5.5 (5.0 to 6.0) 8.6 (7.9 to 9.4)
Free of type 2 diabetes:          
 Life expectancy 28.0 (27.3 to 28.7) 29.8 (29.0 to 30.6) 32.6 (31.7 to 33.4) 34.9 (34.0 to 35.8) 38.4 (37.3 to 39.4)
 Difference Reference 1.7 (1.3 to 2.1) 4.5 (4.1 to 5.0) 6.9 (6.3 to 7.4) 10.3 (9.6 to 11.1)

CVD=cardiovascular diseases.

  • * Included cigarette smoking (never smoking), physical activity (≥3.5 h/week moderate to vigorous intensity activity), high diet quality (upper 40% of Alternate Healthy Eating Index), moderate alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body mass index 18.5-24.9). Multivariate adjusted hazard ratios (sex specific) for mortality and incident diseases associated with lifestyles factors adjusted for age, ethnicity, current multivitamin use, current aspirin use, family history of diabetes, myocardial infarction, or cancer, and menopausal status and hormone use (women only).

The increasing trend of life expectancy free of cancer, cardiovascular disease, and type 2 diabetes associated with increasing number of low risk lifestyle factors was observed across the lifespan after age 50 (supplementary figure B). In the sensitivity analysis in which we stopped updating lifestyle factors after the diagnosis of cancer, cardiovascular disease, or diabetes, women and men with four or five low risk lifestyle factors gained 10.0 (9.3 to 10.3) and 7.2 (6.4 to 7.9) years in their life expectancy free of the major chronic diseases, respectively, compared with those with zero low risk lifestyle factors.

 

Life expectancies free of cancer, cardiovascular disease, or diabetes separately

Women with four or five low risk lifestyle factors had 10.6 (10.0 to 11.3) years’ longer life expectancy free of the major chronic diseases than did women with zero low risk lifestyle factors. When we examined the diseases independently, among women, four to five low risk lifestyle factors were associated with 8.3 (7.8 to 8.9) years’ longer life expectancy without cancer, 10.0 (9.3 to 10.6) more years without cardiovascular disease, and 12.3 (11.4 to 13.4) more years without diabetes (table 2). Among men, compared with those with zero low risk lifestyle factors, participants with four to five low risk lifestyle factors gained 7.6 (6.8 to 8.4) years’ longer life expectancy free of major chronic diseases: 6.0 (5.4 to 6.7) more years without cancer, 8.6 (7.9 to 9.4) more years without cardiovascular disease, and 10.3 (9.6 to 11.1) more years without diabetes (table 2).

 

Life expectancies in presence of cancer, cardiovascular disease, and diabetes

Life expectancy in the presence of cancer, cardiovascular disease, and diabetes was not appreciably different across the groups with different numbers of low risk lifestyle factors (fig 1; supplementary figure B), which was due to a smaller number of patients in the low risk group together with a longer survival time after diagnosis of diseases. Compared with the group with zero low risk lifestyle factors, the hazard ratios for those with four or five low risk lifestyle factors and incident cancer, cardiovascular disease, or type 2 diabetes were 0.5 for women and 0.6 for men (supplementary table B), which means a much lower proportion of incident cancer, cardiovascular disease, or type 2 diabetes among participants with four or five low risk lifestyle factors. After diagnosis of these diseases, half of patients with cancer who adopted four or five low risk lifestyle factors survived up to 22.9 years, whereas half of patients with cancer who adopted zero low risk lifestyle factors survived only up to 11.0 years (supplementary figure C, left); we observed a similar differential survival probability for people with cardiovascular disease (supplementary figure C, middle) and diabetes (supplementary figure C, right). The percentage of life expectancy with presence of cancer, cardiovascular disease, or diabetes out of total life expectancy was 25.2%, 22.4%, 19.9%, 17.8%, and 16.4% among women (24.7%, 24.2%, 23.2%, 22.1%, and 21.0% among men) who adopted zero, one, two, three, and four or five low risk lifestyle factors, respectively.

 

Life expectancies associated with individual lifestyle factors

We also estimated the life expectancy related to each lifestyle factor separately. A healthy dietary pattern, high levels of physical activity, no smoking, moderate alcohol consumption, and an optimal BMI were all associated with longer life expectancy free of cancer, cardiovascular disease, and diabetes (fig 2). The lowest proportions of years of life expectancy free of cancer, cardiovascular disease, or diabetes as a percentage of total life expectancies were observed among men who smoked heavily (≥15 cigarettes/day) and obese men and women (BMI≥30), for whom 75% or less of life expectancy at age 50 years was lived free of these chronic diseases (fig 2).

Fig 2

Fig 2

Estimated life expectancy at age 50 years with and without cancer, cardiovascular disease (CVD), and/or type 2 diabetes among participants of Nurses’ Health Study (women) and Health Professionals Follow-up Study (men) according to levels of individual lifestyle risk factors. Estimates of multivariate adjusted hazard ratios (sex specific) for morbidity and mortality associated with low risk lifestyles compared with people with zero low risk lifestyle factors adjusted for age, ethnicity, current multivitamin use, current aspirin use, family history of diabetes, myocardial infarction, or cancer, and menopausal status and hormone use (women only). AHEI=Alternate Healthy Eating Index; BMI=body mass index; F=fifth. *Cigarettes/day. †Hours/week. ‡Grams/day

In the sensitivity analysis, women who quit smoking for more than 10 years and less than 10 years lost 1.7 and 6.0 years, respectively, of life expectancy free of chronic diseases compared with never smokers; for men, this was 1.9 and 2.6 years among those with more than 10 and less than 10 years smoking cessation, respectively (supplementary figure D). When we included only four lifestyle factors without alcohol, women who adhered to all four low risk lifestyle factors had 9.5 years’ (men: 8.8 years) longer life expectancy free of the major chronic diseases than did those with none of these factors (supplementary figure E, left). After further inclusion of moderate alcohol consumption, women who adhered to all five low risk factors had 12.5 years’ (men: 9.6 years) longer life expectancy free of the major chronic diseases than did those with none of these factors (supplementary figure E, right).

 

Discussion

Using data from two large cohort studies, we observed that adherence to a low risk lifestyle was associated with a longer life expectancy at age 50 free of major chronic diseases of approximately 7.6 years in men and 10 years in women compared with participants with no low risk lifestyle factors.

 

Comparison with other studies

Our results are consistent with previous studies that estimated the individual or clustering effect of lifestyle related risk factors on life expectancy with and without chronic diseases.15 16 17 18 19 Ferrucci et al found that participants aged 65 years who had never smoked and had higher levels of physical activity had life expectancies without disability (self reported need for help or inability to perform basic activities of daily living) of 6.7 years (men) and 7.3 years (women) higher than their peers who had ever smoked and had low levels of physical activity.16 The Framingham Heart Study showed that achieving high levels of physical activity, having a normal weight, and never smoking was associated with lower risk of cardiovascular disease, higher total life expectancy, and greater number of years lived free of cardiovascular disease.17 A large study in Europe found that people with no behavior related risk factors lived six years longer without chronic diseases (cardiovascular disease, cancer, respiratory disease, and diabetes) than did participants with at least two behavior related risk factors (including smoking, physical inactivity, and obesity).18 The CHANCES study found that a healthy lifestyle was associated with a 7.4-15.7 years longer life expectancy at age 50 years and that most of these extra life years were free of chronic diseases.15 Our study extends previous findings by comprehensively assessing five lifestyle risk factors and three major chronic diseases in combination and by providing broader estimates of longevity and the number of years lived with and without disease in relation to lifestyle factors individually and in combination.

We observed a relatively longer gain in life expectancy free of diabetes associated with a low risk lifestyle than the gained life expectancy free of cancer or cardiovascular disease; this was consistent with the result of different preventable attribution fractions for lifestyle related to specific diseases: in our cohorts, 90% of diabetes, 80% of coronary heart disease, 70% of cardiovascular mortality, and 50% of cancer mortality were attributable to not following a low risk lifestyle.9 23 38 We did not observe a significant difference in life expectancy with cancer, cardiovascular disease, and type 2 diabetes across the number of low risk lifestyle factors. However, this does not necessarily imply that a healthy lifestyle has no effect on patients with these conditions. At the population level, the overall life expectancy living with diseases was determined by both the proportion of the population having the diseases and how long they survived after diagnosis. Compared with those with zero low risk lifestyle factors, men and women with four or five low risk factors had a lower rate of incident cancer, cardiovascular disease, and type 2 diabetes, and they also lived longer after diagnosis of these diseases. This resulted in a paradoxical non-differential life expectancy in the presence of cancer, cardiovascular disease, and type 2 diabetes across groups with different numbers of healthy lifestyle factors. A healthy lifestyle not only decreased the risk of incident cancer, cardiovascular disease, and type 2 diabetes but also improved the survival after diagnosis of those diseases.4 15 17 Thus, the proportion of years of life living with chronic diseases was higher among participants who adhered to an unhealthy lifestyle.

Compared with men, women gained a longer life expectancy free of major chronic diseases through adherence to a low risk lifestyle, resulting from the relatively stronger association between low risk lifestyle and incident cancer, cardiovascular disease, diabetes, and mortality among women than men, as observed in our study. Sex differences in the association between lifestyles and healthy life expectancy were also observed in previous studies, but the reasons for this disparity are not clear.15 16 17 18 19 We observed a relatively small difference in life expectancies across different levels of alcohol consumption compared with other individual lifestyle factors. The cardiovascular benefits of moderate alcohol consumption have been consistently observed in large cohort studies,40 but alcohol consumption and risk of cancer showed a dose-response relation.41 42 Thus, current guidelines do not encourage a non-alcohol drinker to start drinking just for the benefit of preventing cardiovascular disease.

 

Strengths and limitations of study

Major strengths of this study are the long term follow-up of two large cohorts with low rates of loss to follow-up and the detailed and repeated measurements of lifestyle factors that enabled us to take the dynamic changes in lifestyle factors over time into account. Nevertheless, we also acknowledge several limitations. Firstly, this study was limited by its reliance on self reported lifestyle factors; measurement errors are inevitable. The use of prospectively collected, cumulatively averaged values based on repeated assessments would reduce the effect of random measurement errors. Secondly, residual and unmeasured confounding might also exist even though we controlled for a wide range of potential confounders. However, only a very strong unmeasured risk factor for mortality together with a very large prevalence imbalance among exposure groups could explain such strong findings.43 44 Thirdly, we included only cancer, cardiovascular disease, and type 2 diabetes because these are highly prevalent diseases, accounting for most chronic diseases, and their associations with lifestyle factors are well documented. The calculated “disease-free” life expectancy would change if we included other diseases, such as respiratory disease or kidney disease; however, the relative differences in disease-free life expectancy across different lifestyle groups should not materially change. Similarly, we did not take into account the severity and clinical complications of the diseases, which could have affected life expectancies. Fourthly, people may have changed their lifestyle after diagnosis of diseases. Nevertheless, our sensitivity analysis taking into account this potential bias showed similar results. Lastly, because our study populations consist of mostly white health professionals who have adopted relatively healthy behaviors, the results may not be generalizable to other populations. Therefore, further studies are warranted to replicate our findings in other ethnic and racial groups and people with other professional backgrounds. However, the biologic effects of unhealthy behaviors are likely to apply to other populations, and the relative homogeneity of the study populations in educational attainment, health awareness, and socioeconomic status reduces residual confounding and enhances the internal validity.

 

Conclusion and public health implications

We observed that a healthier lifestyle was associated with a lower risk of cancer, cardiovascular disease, and diabetes as well as mortality, with an increased total life expectancy and number of years lived free of these diseases. Our findings suggest that promotion of a healthy lifestyle would help to reduce the healthcare burdens through lowering the risk of developing multiple chronic diseases, including cancer, cardiovascular disease, and diabetes, and extending disease-free life expectancy. Public policies for improving food and the physical environment conducive to adopting a healthy diet and lifestyle, as well as relevant policies and regulations (for example, smoking ban in public places or trans-fat restrictions), are critical to improving life expectancy, especially life expectancy free of major chronic diseases.

 

What is already known on this topic

  • Modifiable lifestyle factors including smoking, physical activity, alcohol use, body weight, and diet quality affect both total life expectancy and incidence of chronic diseases

  • Few studies have comprehensively examined how a combination of multiple lifestyle factors may relate to life expectancy free from the major diseases such as diabetes, cardiovascular disease, and cancer

 

What this study adds

  • A healthier lifestyle was associated with an increased total life expectancy and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes

 

Acknowledgments

We thank the participants and staff of the Nurses’ Health Study and the Health Professionals Study who contributed data for their valuable contributions, as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY. The authors assume full responsibility for analyses and interpretation of these data.

 

Footnotes

  • Contributors: YL and JS contributed equally to the paper. YL, JS, OHF, and FBH had the idea for the study. YL did the data analysis. DDW, KD, MS, ML, EH, MS, WCW, OHF, and FBH provided statistical expertise. YL wrote the first draft of the paper. MS, WCW, and FBH obtained funding. All authors contributed to the interpretation of the results and critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. YZ and FBH are the guarantors.

  • Funding: The cohorts were supported by grants of UM1 CA186107, R01 HL034594, R01 HL060712, R01 HL088521, P01 CA87969, UM1 CA167552, and R01 HL35464 from the National Institutes of Health. The funding sources did not participate in the design or conduct of the study; collection, management, analysis or interpretation of the data; or preparation, review, or approval of the manuscript.

  • Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the National Institutes of Health; YL has receiving research support from the California Walnut Commission; AP has received research support from BY-HEALTH outside of the submitted work; FBH has received research support from the California Walnut Commission, and honorariums for lectures from Metagenics and Standard Process, and honorariums from Diet Quality Photo Navigation, outside the submitted work; no other relationships or activities that could appear to have influenced the submitted work.

  • Ethical approval: The Nurses’ Health Study and the Health Professionals Follow-up Study were approved by the institutional review boards at Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health.

  • Data sharing: No additional data available.

  • Transparency statement: The lead author (YL) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

http://creativecommons.org/licenses/by-nc/4.0/

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

References

« BACK TO ALL NEWS

More facts on drinking behaviour during COVID

University of NSW has belled the cat on claims Australians have been consuming alcohol to excess during the pandemic restrictions, by finding two thirds of people either decreased or made no change to their drinking habits. The research can calm the hysteria of those...

ABA Welcomes VIC hospitality decision

Statement by Andrew Wilsmore, CEO, Alcohol Beverages Australia ___ “Finally, Australia is seeing some long-awaited reform in the hospitality sector, more than 20 years after COAG recommended States and Territories achieve a nationally recognised Responsible Service of...

ABA welcomes Tony Ritchie as Director – Media & Communications

Alcohol Beverages Australia (ABA) is pleased to announce the appointment of Mr Tony Ritchie as Director – Media & Communications, effective today, 25 August 2020. Tony will lead ABA’s external and internal communications efforts, showcasing our industry as leaders...

Media Archive

Send this to a friend